Carnitine and its use in reducing cardiac toxicity and as a syne

Details Carnitine and its use in reducing cardiac toxicity and as a syne Carnitine and its use in reducing cardiac toxicity and as a syne

1982-04-22

1987-12-15

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514561, A61K 3170, A61K 31195

Patent

active

047133708

ABSTRACT:
Carnitine may be administered for the purpose of reducing cardiac toxicity resulting from administration of a cytostat. Carnitine may also be administered in combination with cytostats to produce synergistic cytostatic activity.

REFERENCES:
Cancer Chemotherapy Reports, Oct. 1975, vol. 6, No. 2, Merck Index, Ninth Edition, No. 2815.

Affiliated with

Also associated with

Rating

Carnitine and its use in reducing cardiac toxicity and as a syne does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Carnitine and its use in reducing cardiac toxicity and as a syne, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carnitine and its use in reducing cardiac toxicity and as a syne will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1220292